Used primarily in the field of medical research, this compound is investigated for its potential in treating neurodegenerative diseases, particularly Alzheimer's. It functions as a beta-secretase inhibitor, aiming to reduce the production of amyloid-beta peptides, which are believed to play a key role in the progression of Alzheimer's. Clinical trials have been conducted to assess its efficacy and safety in slowing cognitive decline in patients. However, development has faced challenges due to issues with efficacy and side effects, leading to discontinuation in some studies. Ongoing research continues to explore its therapeutic potential and possible applications in other amyloid-related conditions.